Concepedia
Statistics
Publications
8
Citations
284
H-Index
Active since
1972
Affiliations
Eli Lilly (United Kingdom)(Current)
Eli Lilly (United States)
Sally Loomis is an author at Eli Lilly (United Kingdom) specializing in neuroscience, pharmacology, and neuropharmacology.
Publications per year
1972–2019
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia
Gary Gilmour, Elsa Y. Pioli, Sophie Dix et al. · Psychopharmacology · 2009 · 78 citations
Medicine, Neuroscience, Pharmacology +14
Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference
Nick Andrews, Sally Loomis, Robert W. Blake et al. · Psychopharmacology · 2001 · 65 citations
Medicine, Neuroscience, Pharmacology +11
Phenotypic characterization of nonsocial behavioral impairment in neurexin 1α knockout rats.
Frédéric Esclassan, Jennifer François, Keith G. Phillips et al. · Behavioral Neuroscience · 2014 · 55 citations
Life Sciences, Genetics, Neuroscience +17
Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum
Jonathan M. Wilson, Ann Marie L. Ogden, Sally Loomis et al. · Neuropharmacology · 2015 · 32 citations
Life Sciences, Neuroscience, Pharmacology +17
Distinct pro-vigilant profile induced in rats by the mGluR5 potentiator LSN2814617
Sally Loomis, Andrew McCarthy, Christopher Baxter et al. · Psychopharmacology · 2015 · 16 citations · Full text
1–5 of 8